CCN1 and endothelial dysfunction: Collectively, existing literature suggests that novel approaches targeting CCN1 expression or secretion may hold therapeutic potential for treating atherosclerosis by attenuating endothelial dysfunction, foam cell formation, and hepatic lipid accumulation.